The Association Between Liver Histology and Cardiovascular Risk: Time to Introduce Steatotic Liver Disease Screening in High-Risk Patient Groups?
Angiology · 2024
DOI: 10.1177/00033197231201706 ↗Kurz gefasst
Editorial in der Zeitschrift Angiology, 2024. Verfasst von Chrysoula Boutari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.
ORCID-Profile: Chrysoula Boutari, Vasilios G Athyros
Zitieren
APA
Boutari, C., & Athyros, V. G. (2024). The Association Between Liver Histology and Cardiovascular Risk: Time to Introduce Steatotic Liver Disease Screening in High-Risk Patient Groups?. Angiology. https://doi.org/10.1177/00033197231201706
Vancouver
Boutari C, Athyros VG. The Association Between Liver Histology and Cardiovascular Risk: Time to Introduce Steatotic Liver Disease Screening in High-Risk Patient Groups?. Angiology. 2024. doi:10.1177/00033197231201706
BibTeX
@article{Boutari2024,
author = {Boutari, Chrysoula and Athyros, Vasilios G},
title = {The Association Between Liver Histology and Cardiovascular Risk: Time to Introduce Steatotic Liver Disease Screening in High-Risk Patient Groups?},
journal = {Angiology},
year = {2024},
doi = {10.1177/00033197231201706}
}
EUVIMED